Investors

MirZyme has zero debt and is financed by equity. The company intends to progress each of its pipeline of patented products in a way that those that will generate income in the shorter term can finance the development of those that will take longer to bring to market.

News and Media

Publications

 
untitled-1260C_edited.jpg